Search by Drug Name or NDC
NDC 63459-0701-60 AMRIX 30 mg/1 Details
AMRIX 30 mg/1
AMRIX is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cephalon, LLC. The primary component is CYCLOBENZAPRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Cyclobenzaprine is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries. Cyclobenzaprine is in a class of medications called skeletal muscle relaxants. It works by acting in the brain and nervous system to allow the muscles to relax.
Related Packages: 63459-0701-60Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Cyclobenzaprine
Product Information
| NDC | 63459-0701 |
|---|---|
| Product ID | 63459-701_396e049e-2cf9-4dec-b295-a563d917407d |
| Associated GPIs | 75100050107030 |
| GCN Sequence Number | 062178 |
| GCN Sequence Number Description | cyclobenzaprine HCl CAP ER 24H 30 MG ORAL |
| HIC3 | H6H |
| HIC3 Description | SKELETAL MUSCLE RELAXANTS |
| GCN | 97960 |
| HICL Sequence Number | 001950 |
| HICL Sequence Number Description | CYCLOBENZAPRINE HCL |
| Brand/Generic | Brand |
| Proprietary Name | AMRIX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cyclobenzaprine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | CYCLOBENZAPRINE HYDROCHLORIDE |
| Labeler Name | Cephalon, LLC |
| Pharmaceutical Class | Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA021777 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 63459-0701-60 (63459070160)
| NDC Package Code | 63459-701-60 |
|---|---|
| Billing NDC | 63459070160 |
| Package | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (63459-701-60) |
| Marketing Start Date | 2007-11-01 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 55.6197 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | AMRIX ER 30 MG CAPSULE |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis